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Abstract
We earlier identified OSBP-related protein 8 (ORP8) as an endoplasmic reticulum oxysterol-binding protein implicated in
cellular lipid homeostasis. We now investigated its action in hepatic cells in vivo and in vitro. Adenoviral overexpression of
ORP8 in mouse liver induced a decrease of cholesterol, phospholipids, and triglycerides in serum (234%, 226%, 237%,
respectively) and liver tissue (240%,212%,224%), coinciding with reduction of nuclear (n)SREBP-1 and -2 and mRNA levels
of their target genes. Consistently, excess ORP8 reduced nSREBPs in HuH7 cells, and ORP8 overexpression or silencing by
RNA interference moderately suppressed or induced the expression of SREBP-1 and SREBP-2 target genes, respectively. In
accordance, cholesterol biosynthesis was reduced by ORP8 overexpression and enhanced by ORP8 silencing in [3H]acetate
pulse-labeling experiments. ORP8, previously shown to bind 25-hydroxycholesterol, was now shown to bind also cholesterol
in vitro. Yeast two-hybrid, bimolecular fluorescence complementation (BiFC), and co-immunoprecipitation analyses revealed
the nuclear pore component Nup62 as an interaction partner of ORP8. Co-localization of ORP8 and Nup62 at the nuclear
envelope was demonstrated by BiFC and confocal immunofluorescence microscopy. Furthermore, the impact of
overexpressed ORP8 on nSREBPs and their target mRNAs was inhibited in cells depleted of Nup62. Our results reveal that
ORP8 has the capacity to modulate lipid homeostasis and SREBP activity, probably through an indirect mechanism, and
provide clues of an entirely new mode of ORP action.
Citation: Zhou T, Li S, Zhong W, Vihervaara T, Be´aslas O, et al. (2011) OSBP-Related Protein 8 (ORP8) Regulates Plasma and Liver Tissue Lipid Levels and Interacts
with the Nucleoporin Nup62. PLoS ONE 6(6): e21078. doi:10.1371/journal.pone.0021078
Editor: Jean Gruenberg, University of Ge eva, Switzerland
Received March 30, 2011; Accepted May 18, 2011; Published June 15, 2011
Copyright:  2011 Zhou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Academy of Finland (grant 121457 to V.M.O.), from NSFC, China (grant 30971104 to D.Y.), the Fundamental
Research Funds for the Central Universities, China (to D.Y.), the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, The Novo Nordisk
Foundation (V.M.O.), the Liv och Ha¨lsa Foundation, the Magnus Ehrnrooth Foundation (V.M.O.), and the European Union FP7 (LipidomicNet, agreement
no. 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: vesa.olkkonen@helsinki.fi (VMO); tydg@jnu.edu.cn (DY)
Introduction
Cellular cholesterol biosynthesis and uptake, as well as fatty acid
biosynthesis, are controlled by transcription factors named sterol
regulatory element binding proteins (SREBPs) and their sterol-
sensing accessory factor, the SREBP cleavage activating protein
(SCAP) [1–3]. The SREBPs are synthesized as precursors
anchored to endoplasmic reticulum (ER) membranes and
complexed with SCAP. When the cellular cholesterol level is
low, SREBP-SCAP complexes move to the Golgi apparatus,
where SREBPs undergo a two-step proteolytic processing, leading
to the release of an N-terminal fragment, basic helix-loop-helix
leucine zipper transcription factor. These factors enter the nucleus
where they bind to sterol regulatory elements (SRE) in the
promoter regions of a number of genes whose products mediate
the synthesis of cholesterol and fatty acids.
Bidirectional nucleocytoplasmic transport occurs through nu-
clear pore complexes (NPC) embedded in the nuclear envelope.
The vertebrate NPC is a 60–125 MDa structure composed of
approximately 30 distinct proteins called nucleoporins [4,5]. Large
macromolecules are actively transported through its central
channel, while small molecules may diffuse through one of the
eight smaller channels in the symmetrical spoke-ring complex.
Large proteins carrying a classical nuclear localization signal
(NLS) are transported into the nucleus through the following
multistep process: The NLS is recognized by the adaptor protein
importin-a (karyopherin-a). This complex travels to the periphery
of the nucleus where it is bound by a NPC-associated protein,
importin-b, and the entire complex is transported through the
NPC into the nucleus. A subset of the nucleoporins, including
Nup62, are characterized by phenylalanine-glycine rich (FG)
repeat sequences and fill the central channel of the NPC. The FG
domains have an unfolded structure and are responsible for
interaction with importin-cargo complexes moving through the
pore [6,7].
Oxysterol binding protein (OSBP) is a cytoplasmic protein with
affinity for several oxysterols [8–10]. It plays a role in the
trafficking of ceramide from the ER to the Golgi apparatus for
sphinghomyelin synthesis [11], and acts as a sterol-dependent
scaffold that regulates the activity of extracellular signal-regulated
kinases, ERK [12]. Families of proteins displaying sequence
homology to the carboxyl terminal sterol-binding domain of
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OSBP are present in most eukaryotic organisms [13–15]. In
humans the gene/protein family consists of 12 members [16,17].
The mammalian OSBP-related proteins (ORPs) have been
implicated as sterol sensors that regulate cellular functions ranging
from sterol and neutral lipid metabolism to vesicle transport and
cell signaling [18].
ORP8 is a member of the ORP family, with a trans-membrane
segment at its C-terminus specifying localization at the ER. We
have previously reported that ORP8 impacts the expression of
ABCA1 and cellular cholesterol efflux [19]. We now report
functional characterization of ORP8 in hepatic cells and its
interaction with the nucleoporin Nup62, and provide evidence
that ORP8 regulates the abundancy of active nuclear SREBPs
thus impacting lipid metabolism in vivo and in vitro.
Methods
Antibodies and other reagents
Rabbit antibodies against human ORP8 were produced and
affinity-purified as described [19]. Mouse monoclonal anti-
SREBP-2 (clone 1C6) was from BD Biosciences (San Jose, CA),
anti-SREBP-1 and anti-Nup62 from ProteinTech (Chicago, IL),
anti-SREBP-1 from Abcam (Cambridge, UK), and monoclonal
anti-actin (clone JLA20) from the Developmental Studies Hybrid-
oma Bank (Univ. of Iowa).
cDNA constructs and transfection
Full-lengthhumanORP8cDNA(accessionnumberNM_001003712)
was inserted into the XbaI site of pcDNA4HisMaxC (Invitrogen,
Carlsbad, CA). Transient transfections of cultured cells were carried
out using Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s instructions, or by using the NeonTM electrotransfection System
(Invitrogen), achieving.90% transfection frequency. Human ORP1L
(AF323726), ORP3 (NM_015550), andORP10 (NM_017784) cDNAs
in pcDNA4HisMaxC were used for immunofluoresecence micro-
scopy studies. For recombinant protein production, the ORP8 ORD
(aa 242–828) was subcloned into pHAT2 (Dr. Johan Pera¨nen, Institute
of Biotechnology, Univ. of Helsinki).
Construction of recombinant adenoviruses
The human ORP8 cDNA was inserted into pAdenovator-
CMV5-IRES-GFP (QbioGene, Illkirch, France), and recombinant
adenoviruses (AdORP8) were generated in HEK293 cells using
the AdEasy system according to the manufacturer’s instructions.
The viruses constructed with this vector encode GFP under an
IRES sequence. A control adenovirus encoding GFP alone
(AdGFP) was generated from the plain pAdenovator transfer
vector. The recombinant viruses were plaque purified, expanded,
and purified with kit no:631533 from Clontech (Mountain View,
CA).
Intravenous injection of C57B/6 mice
Female C57B/6JOlaHsd mice were purchased from the animal
center of Guangdong Province (Guangzhou, China), housed in a
humidity (40–50%) and temperature (21–22uC) controlled room
with a 12:12 h dark/light cycle, and maintained on Rat&Mouse
Maintenance Diet. For adenovirus injections, 10-week-old animals
were calmed with Hypnorm-Dormicum and injected through the
tail vein with 36108 pfu of adenovirus in 100 l PBS. At 5 days
after injection, the animals were fasted for 6 h, and blood and liver
tissue samples were collected. One mg/ml EDTA was immedi-
ately added in the blood samples and plasma prepared by
centrifugation. All experimental procedures involving animals
were performed in accordance with the Guide for the Care and
Use of Laboratory Animals (NIH publications Nos. 80–23, revised
1996) and according to the institutional ethical guidelines for
animal experiments. The experimental protocols were approved
by the Ethics Committee for Animal Experiments of Jinan
University (permit number 2009210).
Analysis of plasma and liver tissue lipids
Total plasma cholesterol (Cat. no k603, Biovision, Mountain
View, CA), choline-containing phospholipids (Cat. no pl9220,
Jinhao, Beijing, China) and triglycerides (Cat. no etga-200,
Bioassay Systems, Haywards, CA) were measured using fully
enzymatic methods. The total cholesterol assay protocol includes
hydrolysis of cholesterol esters by cholesterol esterase provided
with the kit. The phospholipid analysis involves phospholipase D
digestion to release choline which is quantified by a color reaction
after choline oxidase and peroxidase steps [20]. The Bioassay
Systems triglyceride assay is based on triglyceride hydrolysis by
triacylglycerol acylhydrolase and quantification of the glycerol
released in one step [21].
Sections of liver tissue were excised, snap-frozen in liquid
nitrogen and stored at the temperature of 270uC. Lipids were
extracted from the tissue: Briefly, liver tissue (approximately
100 mg) was homogenized and sonicated in 1 ml of 95%
methanol and mixed with 2 ml of chloroform. The organic phase
was washed with 0.9% NaCl solution and dried under nitrogen.
The residuals were dissolved in 200 ml of tetraethylammonium-
hydroxide (diluted 1:28 with 95% ethanol) and incubated at 60uC
for 30 min with 200 ml of 0.05 M HCl. The formed glycerol was
measured enzymatically (Kit 1488872, Roche Diagnostics, Basel,
Switzerland). Total cholesterol and choline-containing phospho-
lipids (PC, lyso-PC, SM) were measured for the same tissue
specimens from the solvent phase after initial chloroform-
methanol extraction, using the assays specified above for serum
samples.
Cell culture
The human hepatoma cell line HuH7 [22] was cultured in
Eagle’s minimal essential medium with Earle’s salts (EMEM,
Sigma-Aldrich, St. Louis, MO), 20 mM Hepes, pH 7.4, 10%
foetal bovine serum (FBS), penicillin (100 I.U./ml) and strepto-
mycin (100 g/ml). The cells were maintained in 5% CO2, 37uC.
Analysis of nuclear SREBP
Nuclear fractions of liver tissue infected by adenoviruses and
HuH7 cells transfected with ORP8 cDNA or Nup62 siRNA were
isolated according to Blanquart et al. [23]. The specimens were
Western blotted using antibodies against SREBP-1 and -2.
Quantitative real-time RT-PCR
Total RNA was isolated with RNeasy Mini kit (Qiagen,
Valencia, CA), reverse-transcribed using Superscript II (Invitro-
gen) and each RNA sample was amplified in triplicate for the
genes of interest and b-actin as a housekeeping marker, on a 7000
or 7400 Sequence Detection System (Applied Biosystems, Foster
City, CA) using a SYBR Green kit. The primer sequences used are
listed in Table 1. The threshold was set in the linear range of
fluorescence, and a threshold cycle (Ct) for each well was
measured.
RNA interference
The shRNA expression vector pSH-ZsGreen-Neo, which
expresses both Neomycin resistance gene and ZsGreen, was
constructed by PCR amplification of Neomycin resistance gene
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(ORF) with SV40 early polyadenylation signal from pcDNA3.1(+)
(Invitrogen) with primers 59-ATTGGATCCGCCACCATGA-
TTG AACAAGATGGATTGCACG-39 and antisense 59-ATTG-
GATCCGCTCGTATGTTG TGTGGAATTGTGA-39 and in-
serted into BglII restriction site of pSIREN-Retro Q-ZsGreen
under the control of CMV/MSV hybrid promoter. shNT and
shORP8 were synthesized as oligonucleotides, annealed and
inserted into pSH-ZsGreen-Neo via BamHI/EcoRI restriction
sites. The oligonucleotides were: shNT sense, gatccGCATTG-
GTCGTCTCTATTAttcaagagaTAATAGAGACGACCAATG-
Cttttttacgcg tG; antisense, aattcacgcgtaaaaaaGCATTGGTCGT-
CTCTATTAtctcttgaaT AATAGAG-ACGACCAATGCg; shORP8
sense, gatccGAGTGGTCTTGCAAATTATttcaagaga-ATAATTT-
GCAAGACCACTCttttttg; antisense, aattcaaaaaaGAGTGGTCT-
TGCAAA-TTATtctcttgaaATAATTTGCAAGA CCACTCg. For
generation of stably silenced cell lines, HuH7 cells were electro-
transfected with pSH-ZsGreen-Neo constructs linearized usingHindIII
and selected by growth in 600 mg/ml G418 (Gibco) for 14 days. Single
cell clones were generated by limited dilution and screened byWestern
blotting with anti-ORP8. Transient transfection of HuH7 cells with
non-targeting or Nup62-specific siRNAs (sense GCAACAACCA-
CACCUGCUAdTdT, antisense UAGCAGGUGUGGUUGUUG-
CdTdT) in combination with plasmid DNA was carried out using
Lipofectamine 2000 (Invitrogen).
Assay for cholesterol biosynthesis
HuH7 cells cultured on 6-well plates in EMEM (Sigma-
Aldrich), 10% FBS, 20 mM HEPES, pH 7.4, without antibiotics,
transfected with ORP8 cDNA or shRNA constructs, were washed
with serum-free medium. Pulse-labeling was performed for 30 min
at 37uC with [3H]acetic acid (500 mCi/well; GE Healthcare)
followed by a chase period of 90 min in serum-free medium
containing 25 mM mevalonate. After washing with PBS, cells
were scraped into 900 ml of ice-cold 2% (w/v) NaCl. [14C]cho-
lesterol was added to the cell lysates to correct the results for
material losses. Aliquots of 100 ml were withdrawn for protein
analysis. From the remaining 800 ml, lipids were extracted
and separated by TLC on silica-gel plates by using petroleum
ether/diethyl ether/acetic acid (60:40:1) as the solvent. The plates
were dried and stained with iodine vapor. The cholesterol band
was scraped, and [3H] and [14C] radioactivity was measured by
liquid-scintillation counting. The data was normalized for cellular
protein.
Cholesterol binding assay
His6-ORP8 ORD was produced in E.coli Rosetta(DE3)
TM
(Novagen, Madison, WI), and purified on Ni-NTA agarose
(Invitrogen) according to the manufacturer’s instructions, but
omitting detergent from the buffers. The major protein products in
the purified preparation, with the apparent molecular masses of 72
and 67 kDa, were by mass-spectrometry analysis of tryptic
peptides confirmed to represent the ORP8 ORD fusion at the
Meilahti Medical Campus Protein Chemistry Unit.
His6-ORP8 ORD and GST as a negative control protein were
used in an assay measuring the ability to extract [3H]cholesterol
from unilamellar 400 nm diameter vesicles consisting of 99 mol%
egg yolk phosphatidylcholine (Sigma-Aldrich), 1 mol% cholesterol
(Sigma-Aldrich), and [3H]cholesterol (Life Technologies/Amer-
sham TRL330, 44 Ci/mmol). The assays were performed with
vesicle aliquots containing 100 pmol cholesterol, 9.9 nmol PC and
25–100 pmol purified protein according to [24].
Yeast two-hybrid screening
Yeast two-hybrid screening was performed using Matchma-
kerTM GAL4 yeast two-hybrid system 3 (Clontech). cDNA
encoding ORP8 lacking the 19 C-terminal amino acids (designat-
ed as ORP8m), which constitute a putative trans-membrane
anchor, was amplified by PCR with the following primers. Sense:
59-gatcattcatATGAGTCAGCGCCAAGGAAAAG; Antisense:
59-AATGTCGACGTC TTTTTGTTGCAGAAAATAATCC.
The amplified cDNA was cut with NdeI and SalI and inserted
pGBKT7 via the same restriction sites to construct bait plasmid
pGBKT7-ORP8m. The bait plasmid was co-transformed with
plasmids from Human Fetal Kidney MATCHMAKER cDNA
Library (cat. no 638826, Clontech) into Saccharomyces cerevisiae
AH109 strain according to the lithium acetate protocol as
Table 1. Primers used for mRNA quantification by real-time RT-PCR.
Gene Forward primer 59-39 Reverse primer 59- 39
mLDL-R TGACTCAGACGAACAAGGCTG ATCTAGGCAATCTCGGTCTCC
mHMG-CS AACTGGTGCAGAAATCTCTAGC GGTTGAATAGCTCAGAACTAGCC
mHMG-CR CTTGTGGAATGCCTTGTGATTG AGCCGAAGCAGCACATGAT
mFAS GCTGCGGAAACTTCAGGAAAT AGAGACGTGTCACTCCTGGACTT
mACS GCTGCCGACGGGATCAG TCCAGACACATTGAGCATGTCAT
mSCD-1 CCGGAGACCCCTTAGATCGA TAGCCTGTAAAAGATTTCTGCAAACC
mb-actin GGCTGTATTCCCCTCCATCG CCAGTTGGTAACAATGCCATGT
hLDL-R AGCTGCCTCACAGAGGCTGA CCAGAGCTTGGTGAGACATTG
hHMG-CS TGTTTCAGATTGCAAGGTAATATGT CCTGGCACCCAAAAGTTAAA
hHMG-CR TACCATGTCAGGGGTACGTC CAAGCCTAGAGACATAATCAT
hFAS AACTCCAAGGACACAGTCACCAT CAGCTGCTCCACGAACTCAA
hACS AACCACGAACGCTTTGAGA TCCAGATACATTGAGCATGTCAT
hSCD-1 TGTGTCCCAGATGCTGTCAT CCCACCCAATCACAGAAAAG
hb-actin GGCATCCTCACCCTGAAGTA AGGTGTGGTGCCAGATTTTC
The abbreviations are: LDL-R, low-density lipoprotein receptor; HMG-CR, 3-hydroxy-3-methylglutaryl coenzyme A reductase; HMG-CS, 3-hydroxy-3-methylglutaryl
coenzyme A synthetase; FAS, fatty acid synthetase; ACS, acetyl-CoA synthetase; SCD-1, stearoyl-CoA desaturase 1. The prefix m indicates mouse and h human sequence.
doi:10.1371/journal.pone.0021078.t001
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described in the manufacturer’s manual. The plates were grown at
+30uC in a humid incubator for one week, after which the colonies
were subjected to x-gal filter assay for b-galactosidase activity.
Plasmids in colonies positive for b-galactosidase activity were
isolated from yeast and transformed into E. coli strain DH5a for
sequencing.
Bimolecular fluorescence complementation (BiFC)
analysis
To construct BiFC plasmids, the sequences encoding fluore-
scent protein Venus residues 1–172 (Vn) or residues 154–238(Vc)
were connected by C-terminus linker (GGGS)3 (for both Vn
and Vc), or N-terminus linker RSIAT (for Vn) and RPACK-
IPNDLKQKVMNH (for Vc), respectively. Full-length ORP8
cDNA (NM_001003712) and Nup62 cDNA (NM_012346) were
PCR amplified and inserted into BiFC vectors as fusions with the
Vn and Vc fragments. Two combinations of fusion proteins were
tested for BiFC efficency [25]. HuH7 cells were cotransformed
with compatible plasmids encoding the fusion proteins ORP8/
pVcN1 combined with Nup62/pVnC1, or ORP8/pVcC1 com-
bined with Nup62/pVnC1, for identifing interaction of ORP8 and
Nup62, or ORP4L/pVcN1 combined with Nup62/pVnC1 as a
negative control. Plasmid pDsRed2-ER (Clontech) was cotrans-
fected as a transfection efficiency control and as an ER marker.
Overexpression of Nup62 is prone to result in cytosolic aggregates,
as reported previously [26]. We therefore used a limited amount
Nup62 plasmid and added 10 mg/ml cycloheximide to inhibit
protein synthesis at 24 h after transfection, avoiding Nup62
cytosolic aggregates, and further incubated cells for 48 h to allow
overexpressed Nup62 to mature. The cells were incubated for a
total of 72 h at 37uC, and fluorescence emission was imaged at the
RFP and GFP channels.
Co-immunoprecipitation
Aliquots of 107 Huh7 cells were washed twice with ice-cold PBS
and incubated on ice 30 min with 1 ml lysis buffer (50 mM Tris–
Cl, 150 mM NaCl, 0.5 mM MgCl2, 10% glycerol, and 0.5%
Triton X-100, pH 8.0) with Protease Inhibitor Cocktail Set I
(Calbiochem, San Diego, CA) and phosphatase inhibitor cocktails
(Keygen Biotech, Nanjing, China). Cell lysates were centrifuged
for 15 min at 15,0006g at 4uC. The supernatant was preabsorbed
at 4uC for 1 h with 50 ml of rProtein G agarose (Invitrogen). The
recovered supernatant was incubated with ORP8 or control
antibody at 4uC overnight. The lysate–antibody mixture was
added to fresh rProtein G agarose and incubated at 4uC on a roller
for 3 h. Beads were washed five times with lysis buffer and boiled
in 30 ml of 26SDS-PAGE loading buffer. Samples were resolved
on 12% SDS-polyacrylamide gels and subjected to Western blot
analysis.
Immunofluorescence microscopy
HuH7 cells transfected with ORP8/pcDNA4HisMaxC or
the corresponding ORP1L, ORP3, or ORP10 constructs using
Lipofectamine 2000 (Invitrogen) for 24 h were fixed with 4%
paraformaldehyde, permeabilized with 0.05% Triton X-100, and
processed for indirect immunofluorescence microscopy using
antibodies against the ORPs or Nup62 as previously described
[27]. The specimens were analyzed with a TCS SP2 laser
scanning confocal microscope (Leica, Wetzlar, Germany). Fluo-
rescence intensity of nuclear circumference at the Nup62 (green)
and ORP (red) channels was quantified by using the Leica LCS
software.
Results
Adenoviral-mediated expression of ORP8 decreases
plasma and hepatic lipids levels
The recombinant adenovirus encoding ORP8 (AdORP8) or a
control virus encoding GFP (AdGFP) was injected into female
C57B/6 mice through the tail vein at the viral dose 36108 pfu per
animal. This dose was found to result in a moderately elevated, 5-
fold hepatic tissue ORP8 expression level as compared to animals
injected with the control virus (Fig. 1A). The plasma total
cholesterol, triglyceride (TG), and choline-containing phospho-
lipid (PL) concentrations were determined for the mice at 5 days
after AdORP8 injection and revealed a significant reduction of
cholesterol (234%) and TG (237%), as well as tendency of
reduced PL (226%) as compared to AdGFP-transduced animals
(Fig. 1B). Similarly, the liver tissue cholesterol (240%) and TG
(224%) concentrations were markedly decreased in AdORP8-
injected animals (Fig. 1C). In order to elucidate the underlying
mechanism we analyzed by Western blotting the amount of
SREBP-1 and -2 in nuclear fractions prepared from the liver of
the transduced animals, as well as the precursor SREBPs
(pSREBPs) in liver total protein preparations. This analysis
revealed a significant reduction of both nuclear (n)SREBP-1
(235%) and -2 (238%) in the AdORP8-transduced animals,
providing a plausible mechanistic explanation for the observed
lipid changes. Coinciding with the reduction of nSREBPs, mild
increases of the precursor forms of the SREBPs (pSREBP-1 and -
2) were often observed (Fig. 1D). To validate the biological effect
of the reduction of nSREBPs, we quantified the mRNAs for a
number of SREBP-1 and SREBP-2 genes. This analysis revealed
significant decreases of the HMG-CR, LDL-R (predominantly
SREBP-2 target genes), FAS, ACS, and SCD-1 (SREBP-1c target
genes) mRNAs (Fig. 1E), consistent with the observed reduction of
the nSREBPs.
ORP8 modulates SREBP-1 and -2 target gene expression
and cholesterol biosynthesis in HuH7 cells. To further
investigate ORP8 function in a hepatic cell model we employed
the human hepatoma cell line HuH7 which is easily amenable to
transfection. The cells were subjected to ORP8 overexpression or
silencing through RNA interference, followed by quantification of
the mRNAs of the SREBP-2 target genes HGM-CR, HMG-CS, and
LDL-R, and the SREBP-1 target genes FAS, ACS, and SCD-1. The
ORP8-specific shRNA construct reduced the endogenous ORP8
expression by 65%, while the level of overexpression reached was
3-fold as compared to the endogenous level (Fig. 2A). ORP8
silencing induced moderate but significant increases of the HMG-
CS (+110%) and LDL-R (+67%), FAS (+150%), ACS (+92%), and
SCD-1 (+75%) mRNAs (Fig. 2B), while ORP8 overexpression had
the opposite effect, resulting in reduction of the HMG-CR (241%),
LDL-R (228%), FAS (240%), ACS (225%), and SCD-1 (235%)
mRNAs (Fig. 2C). To confirm that the mRNA changes observed
are reflected in cellular lipid metabolism, we measured the
incorporation of [3H]acetate into cholesterol during a 30-min
pulse followed by 90-min chase, in HuH7 cells in which ORP8
was depleted or overexpressed. Cholesterol biosynthesis was
moderately but significantly increased in HuH7 cells transfected
with the ORP8 shRNA construct as compared to a non-targeting
control (Fig. 2D), and decreased to a similar extent in cells
overexpressing ORP8, as compared to cell transfected with the
empty vector plasmid (Fig. 2E).
ORP8 binds cholesterol
To investigate whether ORP8 not only binds 25-hydroxycho-
lesterol [19] but also cholesterol, we assayed the ability of purified
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His6-ORP8 ORD to extract [
3H]cholesterol from unilamellar
PC:cholesterol (99:1) vesicles. These experiments revealed dose-
dependent extraction of cholesterol by His6-ORP8 ORD, which
was significantly above the background release of [3H]cholesterol
observed with the irrelevant control protein, GST (Fig. 3).
ORP8 interacts physically with Nup62
To obtain further clues of ORP8 function we employed the
yeast two-hybrid system to screen for interaction partners of
ORP8m (missing the C-terminal membrane-spanning segment)
employed as bait. A total of 16106 cotransformants were selected
for quadruple prototrophy on SD/-Trp-Leu-His-Ade (SD/4-)
plates, using a human embryonic kidney prey library. Of the
12 colonies growing under the selection and positive for
b-galactosidase activity, eight represented cDNAs encoding
nucleoporin of 62 kDa (Nup62, NM_153719).
To validate the result of the two-hybrid screen, we carried out
bimolecular fluorescence complementation (BiFC) analysis and co-
immunoprecipitation (co-IP) in HuH7 cells. Two BiFC combina-
tions were tested under conditions in which further protein
synthesis was inhibited with cycloheximide (CHX) after 24 h
transfection: Nup62/pVn-C1 (Nup62 fused to the C-terminus of
Vn fragment) with ORP8/pVc-C1 (ORP8 fused to the C-terminus
of Vc fragment) showed a specific BiFC signal at pacthes at the
nuclear circumference that co-localized with the ER marker ER-
DsRed2, while Nup62/pVn-C1 with ORP8/pVc-N1 (ORP8
fused to the N-terminus of Vc fragment) showed no BiFC signal
under the same conditions (Fig. 4A). The specific, spatially
restricted signal given by the former fusion protein pair was
markedly different from the extensive ER/nuclear envelope
localization of ORP8 [19](see also later in this article). If CHX
was not added, both combinations showed a BiFC signal in the
Figure 1. ORP8 overexpression reduces plasma and hepatic lipids in mice. A Western analysis of adenovirus (Ad)-mediated ORP8
overexpression in mouse liver. Liver total protein (20 mg/lane) from mice at day 5 after infection with AdGFP and AdORP8 was Western blotted with
ORP8 antibody. B Plasma Cholesterol (Chol), choline phospholipids (PL), and triglycerides (TG) measured from animals at 5 days after infection with
AdGFP or AdORP8. C Hepatic lipid levels of the mice at day 5. D Mouse liver nuclear (1st and 3rd panel) or total (2nd and 4th panel) protein fractions
(40 mg/lane) at day 5 after infection were Western blotted with antibodies against SREBP-1 or SREBP-2. nSREBP, nuclear SREBP; pSREBP, precursor
SBEBP. (E) Analysis of SREBP target gene mRNAs (identified at the bottom) in the liver of mice transduced with AdGFP (open bars) or AdORP8 (closed
bars) by qPCR. The data represents mean 6 s.e.m. (*p,0.05; **p,0.01; n = 5; t-test).
doi:10.1371/journal.pone.0021078.g001
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cytoplasmic compartment apparently due to aggregation of the
Nup62 fusion. No significant BiFC fluorescence was detectable in
cells expressing ORP4L/pVc-N1 employed as a negative control
and Nup62/pVn-C1 (data not shown). The BiFC analysis thus
suggested a specific interaction of ORP8 with Nup62 at patchy
structures at the nuclear circumference.
Formation of physical complexes between ORP8 and Nup62
was further confirmed by co-IP analysis, in which HuH7 cells
were subjected to immunoprecipitation with anti-ORP8 or an
irrelevant rabbit IgG. Western blot analysis of the immunopre-
cipitates revealed specific co-precipitation of Nup62 with ORP8
(Fig. 4B).
Figure 2. Silencing and overexpression of ORP8 have opposite effects on SREBP target gene expression in HuH7 cells. A Western
analysis of HuH7 cells subjected to ORP8 silencing and overexpression. Stable expression of scrambled control shRNA (shNT) or shORP8, or
overexpression by plasmid transfection for 36 h using NeonTM electroporation (ORP8; Mock = transfection with empty vector). B Quantification of
selected SREBP target gene mRNAs (identified at the bottom) in cells expressing shNT or shORP8. C Quantification of selected mRNAs (identified at
the bottom) in cells transfected with the empty vector (Mock) or ORP8 cDNA (ORP8). D Cholesterol biosynthesis as measured by [3H]acetic acid
incorporation (30 min pulse, 90 min chase), in cells expressing shNT or shORP8. The result is given as % of the biosynthesis in shNT-expressing cells. E
Cholesterol biosynthesis in cells transfected with the plain vector (Mock) or ORP8 cDNA (ORP8) for 36 h. The data represents mean6 s.e.m. (*p,0.05,
**p,0.01, n = 4–6; t-test).
doi:10.1371/journal.pone.0021078.g002
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Identification of the domains responsible for ORP8-
Nup62 interaction
To identify which part of Nup62 interacts with ORP8, deletions
of Nup62 were constructed in the prey vector pGADT7 (Fig. 5A).
Their ability to interact with ORP8 was tested by two-hybrid
assays. The Nup62 C-terminal fragment (aa 328–522) containing a
coiled-coil forming region retained the interaction with ORP8m,
whereas the N-terminal fragment (aa 1–327) with the FG repeat
domain failed to support yeast growth on the selection medium or
activity of the x-gal reporter (Fig. 5B), suggesting that the C-
terminal part of Nup62 with a coiled-coil forming segment
contains the determinant(s) for interaction with ORP8. To
determine which region of ORP8 is involved in the interaction
with Nup62, two deletions of ORP8 in bait vector pGBKT7 were
made (Fig. 5C). The bait construct containing the C-terminal
ORD of ORP8 (aa 242–834) grew on SD/4- selection plates and
activated transcription of the x-gal reporter, whereas the N-
terminal region containing the PH domain (aa 1–305), failed to
interact with Nup62 (Fig. 5D). These results demonstrate that the
ORP8 C-terminal region containing the ORD interacts with
Nup62.
Colocalization analysis of ORP8 and Nup62 by concocal
microscopy
The subcellular localization of ORP8 in HuH7 cells was studied
by immunofluorescence microscopy. Since the antibody available
could not reliably detect the endogenous HuH7 protein, ORP8
was expressed in the cells by transient transfection, and cells were
double stained with anti-ORP8 and anti-Nup62, followed by
confocal fluorescence microscopy (Fig. 6A–C). ORP8 localized at
reticular ER membranes and the nuclear envelope, at which
significant co-localization with Nup62 was evident (arrows),
consistent with results of the BiFC analysis (see Fig. 4A). For a
comparison, we also analyzed the co-localization of Nup62 with
three other ORPs, ORP1L, ORP3, and ORP10. ORP1L and
ORP3 carry instead of a trans-membrane segment, a FFAT (two
phenylalanines in an acidic tract) motif for ER targeting via the
VAMP-associated proteins [28], while ORP10 lacks both the
transmembrane segment and the FFAT motif. No significant co-
localization of Nup62 with these ORP proteins was detected
(Fig. 6D–E), consistent with a specific interaction of ORP8 with
Nup62. Coincidence of the ORP and Nup62 stainings at the
nuclear circumference was further analyzed by using the Leica
LCS software, revealing marked colocalization of Nup62 with
ORP8 and practically none with ORP1L and 3 (Fig. 6G). The
ORP10 signal was somewhat above background levels at the
nuclear envelope region, but did not coincide with the Nup62
fluorescence peaks.
ORP8 interaction with Nup62 results in a decrease of
nuclear SREBPs
To investigate whether interaction of ORP8 with Nup62 could
play a role in the effect of ORP8 on nuclear SREBPs, we
transfected ORP8 cDNA or Nup62 siRNA (siNup62) into HuH7
cells. Like overexpression of ORP8 in liver tissue, excess of this
protein reduced the amount of nSREBPs in HuH7 cells, while no
Figure 3. The ORP8 ligand-binding domain binds cholesterol. A
The purified His6-ORP8 ORD preparation, Coomassie blue stained SDS-
PAGE gel. The two major bands (indicated, ORP8) represent the ORP8
ORD fusion protein. B The ability of His6-ORP8 ORD to extract
[3H]cholesterol from unilamellar PC:cholesterol (99:1 mol%) vesicles
was assayed. Purified GST was used as a negative control. Each assay
contained 9.9 nmol PC and 100 pmol cholesterol; The protein amounts
used (25–100 pmol) are indicated at the bottom. The data represents %
of total DPM extracted from the vesicles, a mean 6 s.e.m. (GST, n = 4;
His6-ORP8 ORD, n = 5).
doi:10.1371/journal.pone.0021078.g003
Figure 4. ORP8 interacts with Nup62. A Bimolecular fluorescence
complementation (BiFC) analysis of ORP8 interaction with Nup62. HuH7
cells were cotransformed for 24 h with plasmids encoding the fusion
proteins Nup62/pVn-C1 and ORP8/pVc-C1 or ORP8pVc-N1 (indicated on
the left) for 24 h, followed by 48 h incubation with 10 mg/ml
cycloheximide. ER-DsRed2 was contransfected as a transfection control
and ER marker. BiFC (GFP channel) and DsRed fluorescence were
imaged (identified at the top). Bar, 10 mm. B Lysate of untransfected
HuH7 cells was immunoprecipitated with anti-ORP8 (identified at the
top) or an irrelevant control IgG, followed by Western blot analysis with
anti-Nup62 (top panel) or anti-ORP8 (bottom panel). H, IgG heavy chain.
doi:10.1371/journal.pone.0021078.g004
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change of nSREBPs was observed in HuH7 cells treated with
Nup62 siRNA (Fig. 7A). For further study, we designed
experiments combining ORP8 overexpression and Nup62 silenc-
ing (Figure 7B–E). We transfected cells with empty vector plasmid
(Mock) and non-targeting control siRNA (siNT), with ORP8 cDNA
and siNT, or with ORP8 cDNA and siNup62, followed by analysis
of nuclear SREBPs. Similar to the results in Fig. 7A, overexpres-
sion of ORP8 in the presence of siNT resulted in a moderate but
significant decrease of nSREBP-1 and -2 as compared with Mock-
transfected cells. Interestingly, this effect was reversed in cells
subjected to knock-down of Nup62 (Fig. 7B–D), suggesting that a
normal level of Nup62 is required for the reduction of nuclear
SREBPs by excess ORP8. To validate the biological significance
of the reversal phenotype induced in ORP8 overexpressing cells by
Nup62 silencing, we quantified mRNAs for SREBP target genes in
cells transfected with siNT+empty vector plasmid, siNT+ORP8
expression plasmid, or with siNup62+ORP8 expression plasmid.
While ORP8 overexpression significantly dampened the expres-
sion of HMG-CR, LDL-R, FAS, ACS, and SCD-1 mRNAs, silencing
of Nup62 in the ORP8 expressing cells reversed the effect in all
cases, bringing the mRNA levels back to control levels (Fig. 7E).
Discussion
We previously identified OSBP-related protein 8 (ORP8) as an
endoplasmic reticulum oxysterol receptor and implicated its role in
cellular lipid metabolism [19]. In the present report, we
demonstrate that moderate adenoviral overexpression of ORP8
in mouse liver significantly reduces the total cholesterol and
triglyceride levels in both plasma and the liver tissue, concomitant
with reduction of the nuclear forms of SREBP-1 and -2 and the
mRNA levels of their target genes controlling cholesterol and fatty
acid biosynthesis as well as LDL uptake. The results were
replicated in the human hepatic cell line HuH7. Both overex-
pression and silencing of ORP8 in HuH7 cells had moderate but
significant effects on the expression of SREBP-1 and -2 target
genes. The observed reduction of nSREBPs provides a plausible
mechanistic explanation for the observed effects on lipid
Figure 5. Identification of the interacting domains in Nup62 and ORP8. A Schematic presentation of the Nup62 prey constructs used in
yeast two-hybrid assays. The numbers indicate amino acid positions. B Interaction of the Nup62 constructs and ORP8m (lacking the C-terminal
trans-membrane segment). Yeast colonies grown on SD/2- plates (left), SD/4- plates (middle) and x-gal assay (right) are shown. C Schematic
presentation of the ORP8 bait constructs used. D Interaction of the ORP8 constructs with Nup62 in the yeast two-hybrid assay. Yeast colonies
grown on SD/2- plates (top), SD/4- plates (middle) and x-gal assay (bottom) are shown. pGADT7 is the empty prey vector and pGBKT7 the empty
bait vector.
doi:10.1371/journal.pone.0021078.g005
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homeostasis. We have earlier shown a related functional effect by
another ORP family member, OSBP, whose overexpression was
shown to increase the quantity of nSREBP-1 and the hepatic
lipogenesis [29].
The reduction of plasma total cholesterol level induced by
ORP8 coincided with a mild down-regulation of mRNAs
encoding both enzymes of the cholesterol biosynthetic pathway
and the LDL receptor. The experiments in the HuH7 cell model
suggest that the reduction of plasma cholesterol may indeed be due
to down-regulation of cholesterol biosynthesis. In mouse, the rate
of hepatic cholesterol clearance is extremely high, resulting in
markedly low serum LDL cholesterol levels [30]. Thus, even
moderate down-regulation of LDL-R might lead to a quite
significant elevation of LDL cholesterol. However, mouse is an
HDL animal with approximately 80% of serum cholesterol found
in the HDL fraction and, as shown by using tissue-specific
inactivation of ATP-binding cassette transporter A1 (ABCA1), the
liver produces at least 70% of serum HDL-cholesterol [31,32]. It is
therefore possible that reduction of cholesterol biosynthesis upon
ORP8 overexpression may impact HDL cholesterol levels at an
extent greater than the putative increase of LDL cholesterol due to
LDL-R down-regulation.
Oxysterols are potent modulators of SREBP maturation.
Radhakrishnan et al. [33] reported that oxysterols act by binding
to Insigs, leading to an inhibition of the transport of Scap-SREBP
complexes to the Golgi apparatus and proteolytic processing of
Figure 6. ORP8 co-localizes with Nup62 at the nuclear envelope: Confocal microscopy analysis. HuH7 cells were transfected with ORP8,
ORP1L, ORP3, or ORP10 cDNA for 24 h using Lipofectamine 2000, followed by processing for confocal immunofluorescence microscopy double
staining with anti-Nup62 (green) and anti-ORP (red) antibodies. A–C Nup62 and ORP8 localization in transfected Huh7 cells. Co-localization of ORP8
and Nup62 at the nuclear envelope is indicated with arrows in the channel merge panel. No Nup62 colocalization was observed with ORP1L (D),
ORP3 (E), or ORP10 (F). Bars, 10 mm. G Analysis of ORP8, 1L, 3, or 10 (identified in the panels) colocalization with Nup62 at the nuclear envelope in
representative cells. Fluorescence intensity (on an arbitrary scale) of the nuclear circumference at the Nup62 (green) and ORP (red) channels was
quantified by using the Leica LCS software.
doi:10.1371/journal.pone.0021078.g006
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the SREBP. We find it likely that ORP8 acts as a sterol sensor
that responds to cellular concentrations of oxysterols or
cholesterol, which we here show it binds, and, via a yet poorly
understood mechanism, fine-tunes the activity of the SREBPs.
Despite efforts, we have not been able to demonstrate effects of
ORP8 manipulation on the suppression of SREBP processing or
target gene expression upon exogenous oxysterol administration.
However, we often detected a mild increase of pSREBPs in
mouse liver or HuH7 cells overexpressing ORP8, indicating that
ORP8 manipulation may, under normal growth conditions
partially inhibit the proteolytic processing of the SREBP
precursors. Interestingly, the present finding that ORP8 interacts
with the nucleoporin Nup62 specifically at the nuclear envelope,
as suggested by the BiFC analysis, provides a clue to a novel type
of regulatory mechanism that may in part explain the impact of
ORP8 on lipid homeostatic control. Experiments combining
ORP8 overexpression with Nup62 knock-down suggested that
depletion of Nup62 with siRNA can at least in part reverse the
suppression of nSREBPs by ORP8. Reduction in the cellular
level of Nup62 alone did not influence the amount of nSREBPs,
suggesting that sequestering of Nup62 in complexes with ORP8
affects nSREBP quantity more strongly than a partial knock-
down of Nup62 with siRNA. These findings are consistent with
the hypothesis that a complex of ORP8 and Nup62 could
modulate the nuclear transport of proteolytically activated
SREBPs.
Figure 7. Nup62 is involved in reduction of nuclear SREBPs by excess ORP8. A HuH7 cells were transfected with empty vector plasmid
(Mock), ORP8 cDNA (ORP8), non-targeting siRNA (siNT) or siNup62 as indicated, followed by preparation of total protein specimens and nuclear
fractions, and Western blot analysis thereof with antibodies against SREBP-1 and SREBP-2. Nuclear SREBPs (nSREBPs) decreased in cells overexpressing
ORP8 (the top panels), while no change in nSREBPs was seen in cells transfected with siNup62 (the two bottom panels). B HuH7 cells were
transfected with combinations of siRNAs and plasmids as indicated at the top. Nuclear fractions Western blotted for SREBP-1 and SREBP-2, and total
protein specimens (40 mg/lane) blotted for Nup62, ORP8, and b-actin are shown at the bottom. C,D Quantification of the relative levels of nSREBP-1
and nSREBP-2 after the indicated combined transfections. E Effect of the combined transfections on the mRNA levels of SREBP target genes
(identified at the bottom); qPCR analysis. The results represent mean 6 s.e.m. (n = 4, *p,0.05, **p,0.01, t-test; difference to values of the siNT and
Mock-transfected control, which was set at 1).
doi:10.1371/journal.pone.0021078.g007
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Steroid receptors and most of the nuclear factors involved in
signaling cascades shuttle constantly between the nucleus and
cytoplasm through the NPC [4]. Nup62 is present in two NPC
modules, the Nup62-Nup58-Nup45-Nup54 and the Nup214-
Nup88-Nup62 subcomplexes [34]. Nup62 is composed of two
major domains: an intrinsically disordered FG-repeat contain-
ing N-terminal domain (aa 1–327) and an a-helical coiled-coil
forming domain (aa 328–522). Nup62 is anchored at the NPC
mainly via its coiled-coil domain [35–37]. Our data suggests
that this domain also mediates binding to ORP8, possibly to a
predicted coiled-coil forming segment located at amino acid
residues 791–815 of ORP8, as determined with the COILS
software (http://www.ch.embnet.org/software/COILS_form.
html). The Nup62 FG-repeat domain, on the other hand,
contributes directly to nucleocytoplasmic transport through
interactions with nuclear transport receptors and with cargo
[38,39]. Nup62 interacts directly with importin-b [40] and with
nuclear transport factor 2 (NTF2) through its FG-repeat domain
[41–43]. In the case of NTF2, this interaction has been shown
to be essential for its transport activity [38,44]. Systematic
analysis of nucleoporin dynamics predicts both transport and
structural roles for Nup62 at the NPC [45,46]. Furthermore,
intermolecular sliding between components of the Nup62-
Nup58-Nup45-Nup54 complex in the central channel of the
NPC is thought to regulate pore diameter [36]. Nup62 medi-
ates the nuclear import of the glucocorticoid receptor-hsp90
complex [47] and of the MUC1-C oncoprotein [48], and a
more general role of Nup62 in protein traffic through NPC has
been indicated [47]. SREBP-2 enters the nucleus through a
direct interaction of its helix-loop-helix leucine zipper domain
with importin-b [49,50] However, the role of Nup62 in the
transport of SREBP-2 or other SREBPs has remained unex-
plored. Our work indicates that ORP8 could, via interaction
with Nup62, modulate the transport of SREBPs through the
NPC. However, we want to emphasize that also other mecha-
nisms are likely to contribute to the observed reduction on
nSREBPs – a detailed mechanistic understanding of the func-
tional role of the ORP8-Nup62 complex requires extensive
future experimentation. A putative function of ORP8 in
complex with Nup62 might also impact nuclear factors other
than the SREBPs, and explain our earlier finding that ORP8
has the capacity to modify ATP-binding cassette transporter A1
(ABCA1) mRNA and protein expression in macrophage, the
underlying mechanism of which remained largely unclear [19].
Like ORP8, its closest homologue in ORP subfamily IV, ORP5,
is anchored to ER membranes via a C-terminal transmembrane
segment and displays localization highly similar to that of ORP8,
including distribution to the nuclear envelope [51]. Furthermore,
Nup62 interacts with the sterol-binding domain of ORP8, a region
highly conserved between ORP5 and ORP8 [16]. It is therefore
possible that also ORP5 could interact with Nup62, although we
at this point have no evidence for such an interaction.
The present findings suggest that ORP8 has the capacity to
regulate hepatic lipogenesis and plasma lipid levels, apparently
through modulation of the quantity of the active nuclear forms of
SREBPs. Although the underlying mechanisms remain incom-
pletely understood, we find it likely that the newly discovered
interaction of ORP8 with Nup62 may be involved. This finding
also adds a novel, intriguing aspect in the study of OSBP-related
protein function. Future work with an ORP8 knock-out mouse
model under construction is necessary for a comprehensive
understanding of the role that this protein plays in lipid
metabolism.
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